Comparing Editas Medicine (NASDAQ:EDIT) & Crispr Theraptc (CRSP)The Ledger GazetteCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Francise… Continue reading
Cellular Biomedicine Group (CBMG) Reports Strategic Partnership with Thermo Fischer Scientfic (TMO) China to …StreetInsider.com“Break-through cell therapy technology such as CAR-T provides unprecedented medical needs to cancer patients, yet the succe… Continue reading
Timing, Sequencing of Immunotherapy Combination May Improve Mesothelioma ResponseMesotheliomaHelp.org (blog)In September, MesotheliomaHelp reported on researchers taking a closer look at immune cells to help identify those patients who may respond best… Continue reading
Bennington Banner |
Baby gene therapy study offers hope for fatal muscle disease
Bennington Banner Dr. Jerry Mendell of the Center for Gene Therapy at Nationwide Children’s Hospital in Columbus, Ohio. Mendell led a small study of gene therapy in babies born with a usually fatal neuromuscular disease and reported Nov. 1 that the experiment extended … |
Bennington Banner |
Baby gene therapy study offers hope for fatal muscle disease
Bennington Banner Dr. Jerry Mendell of the Center for Gene Therapy at Nationwide Children’s Hospital in Columbus, Ohio. Mendell led a small study of gene therapy in babies born with a usually fatal neuromuscular disease and reported Nov. 1 that the experiment extended … |
|
Sarepta Therapeutics (SRPT): FDA Clears GALGT2 Gene Therapy Program – William Blair
StreetInsider.com William Blair analyst, Tim Lugo, reiterated his Outperform rating on shares of Sarepta Therapeutics (NASDAQ: SRPT) after the company announced the FDA had approved an investigational new drug (IND) application for its GALGT2 gene therapy program … Sarepta Therapeutics and Nationwide Children’s Hospital Announce FDA Clearance of IND for Micro-Dystrophin Gene …GlobeNewswire (press release) |